Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Utility of the DxN HCV Assay as an Aid in the Management of HCV-Infected Individuals Undergoing Antiviral Therapy

NCT03125408 is registered in ClinicalTrials.gov with Beckman Coulter, Inc. as lead sponsor.

NCT NCT03125408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03125408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Utility of the DxN HCV Assay as an Aid in the Management of HCV-Infected Individuals Undergoing Antiviral Therapy
Lead sponsor
Beckman Coulter, Inc.
Phase
Observational
Overall status
Terminated
Start date
May 2, 2012
Completion date
August 30, 2017
Enrollment
210 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c